0.7(top 50%)
impact factor
37(top 100%)
papers
1.0K(top 50%)
citations
16(top 50%)
h-index
0.7(top 50%)
extended IF
40
all documents
1.1K
doc citations
31(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Intestinal Microbes in Inflammatory Bowel DiseasesAmerican Journal of Gastroenterology Supplements (Print)2012165
2Impact of the Gut Microbiota on the Development of Obesity: Current ConceptsAmerican Journal of Gastroenterology Supplements (Print)2012112
3Molecular Physiology of Enteric Opioid ReceptorsAmerican Journal of Gastroenterology Supplements (Print)2014105
4Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal DisordersAmerican Journal of Gastroenterology Supplements (Print)201294
5Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic ApproachAmerican Journal of Gastroenterology Supplements (Print)201491
6The Narcotic Bowel Syndrome: A Recent UpdateAmerican Journal of Gastroenterology Supplements (Print)201467
7Methanogens in Human Health and DiseaseAmerican Journal of Gastroenterology Supplements (Print)201264
8Using Probiotics in Gastrointestinal DisordersAmerican Journal of Gastroenterology Supplements (Print)201259
9The Intestinal Microbiota and Liver DiseaseAmerican Journal of Gastroenterology Supplements (Print)201246
10Therapeutic Targets in Inflammatory Bowel Disease: Current and FutureAmerican Journal of Gastroenterology Supplements (Print)201646
11An Evidence-Based Review of Novel and Emerging Therapies for Constipation in Patients Taking Opioid AnalgesicsAmerican Journal of Gastroenterology Supplements (Print)201436
12Pharmacology of Opioids and their Effects on Gastrointestinal FunctionAmerican Journal of Gastroenterology Supplements (Print)201433
13Chronic Health Consequences of Acute Enteric Infections in the Developing WorldAmerican Journal of Gastroenterology Supplements (Print)201625
14Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusAmerican Journal of Gastroenterology Supplements (Print)201623
15Postinfectious Chronic Gut Dysfunction: From Bench to BedsideAmerican Journal of Gastroenterology Supplements (Print)201221
16The Use of Opioid Analgesics for Chronic Pain: Minimizing the Risk for HarmAmerican Journal of Gastroenterology Supplements (Print)201421
17Incidence and Clinical Presentation of Gastrointestinal Bleeding in Atrial Fibrillation Patients Taking Direct Oral AnticoagulantsAmerican Journal of Gastroenterology Supplements (Print)201615
18Prevention of Gastrointestinal Bleeding in Patients Receiving Direct Oral AnticoagulantsAmerican Journal of Gastroenterology Supplements (Print)201612
19Chronic Health Consequences of Acute Enteric Infections in the Developed WorldAmerican Journal of Gastroenterology Supplements (Print)201611
20Novel Therapies in Inflammatory Bowel Disease: An Evaluation of the EvidenceAmerican Journal of Gastroenterology Supplements (Print)201610
21Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusAmerican Journal of Gastroenterology Supplements (Print)201610
22Established Management Paradigms in IBD: Treatment Targets and Therapeutic ToolsAmerican Journal of Gastroenterology Supplements (Print)20167
23Good Bugs, Bad Bugs in the Gut: The Role of Microbiota Dysbiosis in Chronic Gastrointestinal Consequences of InfectionAmerican Journal of Gastroenterology Supplements (Print)20166
24Risks to Reversal of Anticoagulation: The Cardiology PerspectiveAmerican Journal of Gastroenterology Supplements (Print)20165
25The Specific Direct Oral Anticoagulant Reversal Agents: Their Current Status and Future Place in Gastroenterology PracticeAmerican Journal of Gastroenterology Supplements (Print)20163
26The Microbiome–Gut–Brain Axis and the Consequences of Infection and DysbiosisAmerican Journal of Gastroenterology Supplements (Print)20163
27Endoscopy for Gastrointestinal Bleeding in Patients Treated With Direct Oral AnticoagulantsAmerican Journal of Gastroenterology Supplements (Print)20162
28Refining Treatment Paradigms in Inflammatory Bowel Disease: Assessing the Options for Individualized TherapyAmerican Journal of Gastroenterology Supplements (Print)20162
29Genetics, Mucosal Inflammation and the Environment in Post-Infectious Chronic Gut SyndromesAmerican Journal of Gastroenterology Supplements (Print)20162
30Assessment and Management of Gastrointestinal Hemorrhage in the Setting of Direct Oral Anticoagulants: The Hematology PerspectiveAmerican Journal of Gastroenterology Supplements (Print)20162
31Introduction: Opioid-Induced ConstipationAmerican Journal of Gastroenterology Supplements (Print)20141
32Intestine Microbes in Gastroenterology: Health and DiseaseAmerican Journal of Gastroenterology Supplements (Print)20120
33Continuing Medical Education: September 2014American Journal of Gastroenterology Supplements (Print)20140
34Continuing Medical Education: Post TestAmerican Journal of Gastroenterology Supplements (Print)20160
35Autoimmunity and Irritable Bowel Syndrome: New PathophysiologyAmerican Journal of Gastroenterology Supplements (Print)20160
36Persisting Consequence of Intestinal Infection: A Case of the Blind Men and the ElephantAmerican Journal of Gastroenterology Supplements (Print)20160
37Continuing Medical Education: November 2016 InstructionsAmerican Journal of Gastroenterology Supplements (Print)20160